Completed PHASE2 INTERVENTIONAL NCT00653042

Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA

A Pilot, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Nesiritide Infusion, Initiated Post-Induction of Anesthesia, in the Management of Coronary Artery Bypass Graft (CABG) Patients Requiring CardioPulmonary Bypass (CPB)

Sponsor: Scios, Inc.

Conditions Cardiopulmonary Bypass Congestive Heart Failure Coronary Artery Bypass Grafting Coronary Artery Bypass Surgery Coronary Heart Disease Ischemic Heart Disease

Interventions Nesiritide

Updated 5 times since 2017 Last updated: May 18, 2011 Started: Mar 31, 2004 Completion: Jun 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00653042, this PHASE2 trial focuses on Cardiopulmonary Bypass and Congestive Heart Failure and remains completed. Sponsored by Scios, Inc., it has been updated 5 times since 2004, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Scios, Inc.

Data source: Scios, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.